Are you kidding? No need to try an expensive experimental drug like AICAR. Google Telmisartan and doping. Guess what? It's "legal."
Telmisartan:
Telmisartan is a prescription drug for high blood pressure. It’s accepted by the U.S. Food and Drug Administration and not on the WADA list, nor is the class of drugs to which it belongs. Only specifically named substances and substances that are not approved by government regulatory bodies are on that list.
Telmisartan is neither and, according to recent research by Fabian Sanchis Gomar of the University of Valencia, Spain, it has virtually the same specifics as AICAR and GW1516. It also enhances running ability in mice if they are completely untrained. With training, endurance increases, fat is burnt and recovery is faster as there is less lactic acid formation.
Both WADA and the Dutch anti-doping authority know of Telmisartan but they say they are not convinced of the effects reported by the study by Sanchis-Gomar. “Recent scientific research does not seem to validate that claim,” WADA spokesmen O’Rorke insisted.
Herman Ram added that there is a thin line between what is admissible and what not. “In the end everything has an effect on something. So far there hasn’t been a reason to take a closer look on Telmisartan in this respect.”
Meanwhile, the substance has been found near cycling. During the same Tour de France raid in 2009 the AFLD-researchers found packages of Telmisartan. This was before research claimed similar characteristics as AICAR, and AFLD therefore couldn’t really explain its presence in a cycling-related environment.
Every chemist has access to Telmisartan and because it’s not experimental anymore, it is therefore widely available. If AICAR is on WADA’s forbidden list and Telmisartan - which might have the same effects - isn’t, the latter might be a way to escape detection.
More research is needed in relation to these substances, particularly as those seeking to gain unfair advantage will always try to cut corners and gain advantage over WADA and the rest of the peloton.